60 related articles for article (PubMed ID: 1518180)
1. [Analysis of platelet shape change, inositol metabolism, and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W
Rinsho Byori; 1992 Mar; 40(3):287-96. PubMed ID: 1518180
[TBL] [Abstract][Full Text] [Related]
2. [PI metabolism and Ca mobilization in patients with platelet dysfunction].
Fuse I; Hattori A; Higuchi W; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):237-43. PubMed ID: 1535386
[TBL] [Abstract][Full Text] [Related]
3. Characterization of platelet cytoplasmic Ca2+ mobilization in patients with congenital cyclo-oxygenase deficiency and with defective platelet aggregation to A23187.
Fuse I; Hattori A; Nagayama R
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1522-33. PubMed ID: 2516953
[TBL] [Abstract][Full Text] [Related]
4. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
5. Concomitant defect in internal release and influx of calcium in patients with congenital platelet dysfunction and impaired agonist-induced calcium mobilization. Thromboxane production is not required for internal release of calcium.
Rao AK; Disa J; Yang X
J Lab Clin Med; 1993 Jan; 121(1):52-63. PubMed ID: 8426081
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
7. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
[TBL] [Abstract][Full Text] [Related]
9. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
James-Kracke MR; Sexe RB; Shukla SD
J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
[TBL] [Abstract][Full Text] [Related]
10. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
12. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML
J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
Siess W; Lapetina EG
Biochem J; 1988 Oct; 255(1):309-18. PubMed ID: 3143357
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
Li BY; Zhou YC; Li WH
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
[TBL] [Abstract][Full Text] [Related]
15. [The regulatory mechanism of free Ca2+ concentration in activated platelets].
Sakon M; Kambayashi J
Nihon Rinsho; 1992 Feb; 50(2):249-53. PubMed ID: 1319511
[TBL] [Abstract][Full Text] [Related]
16. Measurement of IP3 mass as a monitor of phospholipase C activation in stimulated human platelets.
Rittenhouse SE; Sasson JP
Nouv Rev Fr Hematol (1978); 1985; 27(4):239-42. PubMed ID: 3877271
[TBL] [Abstract][Full Text] [Related]
17. Analysis of platelet cytoskeleton assembly during platelet activation in Hermansky-Pudlak syndrome and thrombasthenia.
Fujimura K; Fujimoto T; Takemoto M; Oda K; Shimomura T; Maehama S; Kuramoto A
Thromb Haemost; 1990 Feb; 63(1):103-11. PubMed ID: 2339346
[TBL] [Abstract][Full Text] [Related]
18. The correlation between Ca2+ influx and inositol 1, 4, 5-trisphosphate (IP3) formation in platelets stimulated by various agonists.
Uemura Y; Sakon M; Kawasaki T; Shiba E; Kambayashi J; Mori T
Biochem Int; 1990; 20(5):853-61. PubMed ID: 2112382
[TBL] [Abstract][Full Text] [Related]
19. Impairment of phosphatidylinositol metabolism in a patient with a bleeding disorder associated with defects of initial platelet responses.
Lages B; Weiss HJ
Thromb Haemost; 1988 Apr; 59(2):175-9. PubMed ID: 2838922
[TBL] [Abstract][Full Text] [Related]
20. Familial bleeding disorder associated with deficiencies in platelet signal processing and glycoproteins.
Holmsen H; Walsh PN; Koike K; Murphy S; Holme S; Johnson MM; Dangelmaier CA; Egan JJ; Benzel JE; Tuszynski GP
Br J Haematol; 1987 Nov; 67(3):335-44. PubMed ID: 3689696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
